Anticoagulant agents useful in treatment of thrombosis
n anti-factor IX monoclonal antibody having self-limiting neutralizing activity against Factor IX and the identifying characteristics of SB 249413, SB 249415, SB 249417, SB 257731 or SB 257732 is claimed. Also claimed are an immunoglobulin heavy chain complementary determining region having an amino...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | n anti-factor IX monoclonal antibody having self-limiting neutralizing activity against Factor IX and the identifying characteristics of SB 249413, SB 249415, SB 249417, SB 257731 or SB 257732 is claimed. Also claimed are an immunoglobulin heavy chain complementary determining region having an amino acid sequence selected from SEQ. ID NO 8, 9 and 10 as defined in the specification and the nucleic acid molecule encoding it. Also claimed are an immunoglobulin light chain complementary determining region having an amino acid sequence selected from SEQ. ID NO 12, 13 and 14 as defined in the specification and the nucleic acid molecule encoding it. Divisional filed as 501215 |
---|